Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
278
278 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- NXC736Phase 21 trial
NEXTGEN Bioscience · Alopecia Areata
- OD-07656Phase 21 trial
Odyssey Therapeutics, Inc. · Ulcerative Colitis (UC), UC - Ulcerative Colitis
- OLX72021Phase 21 trial
Olix Pharmaceuticals, Inc. · Androgenetic Alopecia (AGA)
- PALI-2108Phase 21 trial
Palisade Bio · Ulcerative Colitis (UC), Severe Ulcerative Colitis, Moderate Ulcerative Colitis
- PDFE-2304Phase 21 trial
PDFE Pharma Innovations FZCO · Alopecia, Androgenetic, Baldness, Androgenetic Alopecia (AGA)
- PF-07264660Phase 21 trial
Pfizer · Atopic Dermatitis
- PF-08049820Phase 21 trial
Pfizer · Atopic Dermatitis, Eczema, Atopic
- PF-08154225Phase 21 trial
Pfizer · Systemic Lupus Erythematosus, Rheumatoid Arthritis, Idiopathic Inflammatory Myositis
- PL8177Active study medicationPhase 21 trial
Palatin Technologies, Inc · Ulcerative Colitis, Ulcerative Colitis Acute, Ulcerative
- PTC844Phase 21 trial
PTC Therapeutics · Rheumatoid Arthritis
- PTT-621Phase 21 trial
Pyrotech Therapeutics, Inc. · Ulcerative Colitis (UC)
- QEL-005Phase 21 trial
Quell Therapeutics Limited · Diffuse Cutaneous Systemic Sclerosis, Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc)
- RavagalimabPhase 21 trial
AbbVie · Rheumatoid Arthritis
- RO7837195Phase 21 trial
Roche (Genentech) · Ulcerative Colitis
- RSLV-132Phase 21 trial
Resolve Therapeutics · Primary Sjögren Syndrome
- SAR441566Phase 21 trial
Sanofi · Rheumatoid Arthritis
- SAR445399Phase 21 trial
Sanofi · Hidradenitis Suppurativa
- SCT650CPhase 21 trial
Sinocelltech Ltd. · Hidradenitis Suppurativa (HS)
- SHR-3045Phase 21 trial
Guangdong Hengrui Pharmaceutical Co., Ltd · Moderate to Severe Active Rheumatoid Arthritis
- SIM0278Phase 21 trial
Jiangsu Simcere Pharmaceutical Co., Ltd. · Atopic Dermatitis (AD)
- STMC-103HPhase 21 trial
Siolta Therapeutics, Inc. · Atopic Dermatitis, Type 1 Hypersensitivity
- TAVO101Phase 21 trial
Tavotek Biotherapeutics · Atopic Dermatitis
- TRIV-509Phase 21 trial
Triveni Bio · Atopic Dermatitis
- TRIV-573Phase 21 trial
Triveni Bio · Atopic Dermatitis
- TRX103Phase 21 trial
Tr1X, Inc. · Crohns Disease
- UCB1381Phase 21 trial
UCB · Atopic Dermatitis
- XmAb942Phase 21 trial
Xencor, Inc. · Ulcerative Colitis (UC)
- YR001Phase 21 trial
Hangzhou Yirui Pharmaceutical Technology Co., Ltd · Atopic Dermatitis
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.